Inversago Pharma
John Babetas, PMP, currently serves as Senior Manager of Preclinical Development at Inversago Pharma since April 2023. Prior to this role, John held various positions at CellCarta from April 2016 to April 2023, including Program Manager in Global Program Management and Senior Principal Scientist in Proteomics. John’s earlier experience includes roles at GlaxoSmithKline Vaccines as Analytical Project Coordinator and Scientist in Analytical Development, as well as positions at IDB Biomedical Inc and Xanthus Life Sciences Inc focused on analytical methods and immunoassays. John's career began with research at the Montreal General Hospital Research Institute, working on the characterization of Wilson disease protein. John holds a Bachelor of Science degree in Biochemistry from Concordia University, complemented by training in Agile practices.
This person is not in any offices
Inversago Pharma
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH).